Journal of Reproductive Immunology
Volume 78, Issue 2 , Pages 134-139 , July 2008

Evaluation of the use of anti-TNF-α in an LPS-induced murine model

  • C. Holmgren

      Affiliations

    • University of Utah Health Sciences Center, Department of Obstetrics and Gynecology, Salt Lake City, UT, USA
    • Intermountain Health Care, Department of Obstetrics and Gynecology, Salt Lake City, UT, USA
    • Corresponding Author InformationCorresponding author at: Room 2B, 200 SOM, 30 North 1900 East, Salt Lake City, Utah 84132, USA.
    • ,
  • M.S. Esplin

      Affiliations

    • University of Utah Health Sciences Center, Department of Obstetrics and Gynecology, Salt Lake City, UT, USA
    • Intermountain Health Care, Department of Obstetrics and Gynecology, Salt Lake City, UT, USA
    • ,
  • S. Hamblin

      Affiliations

    • University of Utah Health Sciences Center, Department of Obstetrics and Gynecology, Salt Lake City, UT, USA
    • ,
  • M. Molenda

      Affiliations

    • Centacor, Malvern, PA, USA
    • ,
  • S. Simonsen

      Affiliations

    • University of Utah Health Sciences Center, Department of Obstetrics and Gynecology, Salt Lake City, UT, USA
    • ,
  • R. Silver

      Affiliations

    • University of Utah Health Sciences Center, Department of Obstetrics and Gynecology, Salt Lake City, UT, USA

Received 31 May 2007 ,Revised 1 October 2007 ,Accepted 6 November 2007.

References 

  1. Ananth CV, Joseph KS, Oyelese Y, Demissie K, Vintzileos AM. Trends in preterm birth and perinatal mortality among singletons: United States, 1989 through 2000. Obstet. Gynecol. 2005;105:1084–1091
  2. Arias E, MacDorman MF, Strobino DM, Guyer B. Annual summary of vital statistics. Pediatrics. 2003;112:1215
  3. Arnott I, McDonald D, Williams A, Ghosh S. Clinical use of Infliximab in Crohn's disease: the Edinburgh experience. Aliment. Pharmacol. Ther. 2001;15:1639–1646
  4. Blumenauer B, Judd M, Cranney A, et al. Etanercept for the treatment of rheumatoid arthritis. Cochrane Database Syst. Rev. 2003;CD004525
  5. Chakravarty EF, Sanchez-Yamamoto D, Bush TM. The use of disease modifying antirheumatic drugs in women with rheumatoid arthritis of childbearing age: a survey of practice patterns and pregnancy outcomes. J. Rheumatol. 2003;30:241–246
  6. Crider K, Whitehead N, Buus R. Genetic variation associated with preterm birth: a HuGE review. Genet. Med. 2005;7:593–604
  7. Elovitz MA, Mrinalini C. Can medroxyprogesterone acetate alter Toll-like receptor expression in a mouse model of intrauterine inflammation?. Am. J. Obstet. Gynecol. 2005;193:1149–1155
  8. Fidel P, Romero R, Cutright J, et al. Treatment with the interleukin-I receptor antagonist and soluble tumor necrosis factor receptor Fc fusion protein does not prevent endotoxin-induced preterm parturition in mice. J. Soc. Gynecol. Investig. 1997;4:22–26
  9. Fidel PL, Romero R, Wolf N, et al. Systemic and local cytokine profiles in endotoxin-induced preterm parturition in mice. Am. J. Obstet. Gynecol. 1994;170:1467–1475
  10. Fortunato SJ, Menon RP, Swan K, Menon R. Inflammatory cytokine (interleukins 1, 6 and 8 and tumor necrosis factor-alpha) release from cultured human fetal membranes in response to endotoxic lipopolysaccharide mirrors amniotic fluid concentrations. Am. J. Obstet. Gynecol. 1996;174:1855–1861
  11. Fujihara M, Muroi M, Tanamoto K, Suzuki T, Azuma H, Ikeda H. Molecular mechanisms of macrophage activation and deactivation by lipopolysaccharide: roles of the receptor complex. Pharmacol. Ther. 2003;100:171–194
  12. Gendron R, Nestel F, Lapp W, Baines M. Lipopolysaccharide-induced fetal resorption in mice is associated with the intrauterine production of tumour necrosis factor-alpha. J. Reprod. Fertil. 1990;90:395–402
  13. Gravett MG, Novy MJ, et al. Diagnosis of intra-amniotic infection by proteomic profiling and identification of novel biomarkers. JAMA. 2004;292:462–469
  14. Hamilton BE, Martin JA, Sutton PD. Births: preliminary data for 2002. In National Vital Statistics Reports from the Centers for Disease Control and Prevention. vol. 51. National Center for Health Statistics, National Vital Statistics System; 2003;pp. 1–20
  15. Hillier SL, Martius J, Krohn M, Kiviat N, Holmes KK, Eschenbach DA. A case-control study of chorioamnionitis in prematurity. N. Engl. J. Med. 1988;319:972–978
  16. Hirsch E, Filipovich Y, Mahendroo M. Signaling via the type I IL-1 and TNF receptors is necessary for bacterially induced preterm labor in a murine model. Am. J. Obstet. Gynecol. 2006;194:1334–1340
  17. Hirsch E, Muhle R, Mussalli G, Blanchard R. Bacterially induced preterm labor in the mouse does not require maternal interleukin-1 signaling. Am. J. Obstet. Gynecol. 2002;186:523–530
  18. Hirsch E, Wang H. The molecular pathophysiology of bacterially induced preterm labor: insights from the murine model. J. Soc. Gynecol. Investig. 2005;12:145–155
  19. Katz JA, Antoni C, Keenan GF, Smith DE, Jacobs SJ, Lichtenstein GR. Outcome of pregnancy in women receiving infliximab for the treatment of Crohn's disease and rheumatoid arthritis. Am. J. Gastroenterol. 2004;99:2385–2392
  20. Kim YM, Romero R, Chaiworapongsa T, et al. Toll-like receptor-2 and -4 in the chorioamniotic membranes in spontaneous labor at term and in preterm parturition that are associated with chorioamnionitis. Am. J. Obstet. Gynecol. 2004;191:1346–1355
  21. Lin Y, Xie M, Chen Y, Di J, Zeng Y. Preterm delivery induced by LPS in syngeneically impregnated BALB/c and NOD/SCID mice. J. Reprod. Immunol. 2006;71:87–101
  22. Moore KW, de Waal Malefyt R, Coffman RL, O’Garra A. Interleukin-10 and the interleukin-10 receptor. Annu. Rev. Immunol. 2001;19:683–765
  23. Muzio M, Polentarutti N, Bosisio D, Manoj Kumar PP, Mantovani A. Toll-like receptor family and signalling pathway. Biochem. Soc. Trans. 2000;28:563–566
  24. Pestka S, Krause CD, Sarkar D, Walter MR, Shi Y, Fisher PB. Interleukin-10 and related cytokines and receptors. Annu. Rev. Immunol. 2004;22:929–979
  25. Rath W, Winkler M, Kemp B. The importance of extracellular matrix in the induction of preterm delivery. J. Perinat. Med. 1998;26:437–441
  26. Robertson SA, Skinner RJ, Care AS. Essential role for IL-10 in resistance to lipopolysaccharide-induced preterm labor in mice. J. Immunol. 2006;177:4888–4896
  27. Romero R, Mazor M. Infection and preterm labor. Clin. Obstet. Gynecol. 1988;31:553–584
  28. Romero R, Mazor M, Sepulveda W, Avila C, Copeland D, Williams J. Tumor necrosis factor in preterm and term labor. Am. J. Obstet. Gynecol. 1992;166:1576–1587
  29. Romero R, Sirtori M, Oyarzun E, Avila C, Mazor M, Callahan R. Infection and labor. V. Prevalence, microbiology, and clinical significance of intraamniotic infection in women with preterm labor and intact membranes. Am. J. Obstet. Gynecol. 1989;161:817–824
  30. Sadowsky DW, Adams KM, Gravett MG, Witkin SS, Novy MJ. Preterm labor is induced by intraamniotic infusions of interleukin-1beta and tumor necrosis factor-alpha but not by interleukin-6 or interleukin-8 in a nonhuman primate model. Am. J. Obstet. Gynecol. 2006;195:1578–1589
  31. Silver RM, Edwin SS, Umar F, Dudley DJ, Branch DW, Mitchell MD. Bacterial lipopolysaccharide-mediated murine fetal death: the role of interleukin-1. Am. J. Obstet. Gynecol. 1997;176:544–549
  32. Silver R, Lohner W, Daynes R, Mitchell M, Branch D. Lipopolysaccharide-induced fetal death: the role of tumor-necrosis factor-alpha. Biol. Reprod. 1994;50:1108–1112
  33. Tanaka Y, Narahara H, Takai N, Yoshimatsu J, Anai T, Miyakawa I. Interleukin-1ß and interleukin-8 in cervicovaginal fluid during pregnancy. Am. J. Obstet. Gynecol. 1998;79:644–649
  34. Xu D, Chen Y, Wang H, Zhao L, Wang J, Wei W. Tumor necrosis factor alpha partially contributes to lipopolysaccharide-induced intra-uterine fetal growth restriction and skeletal development retardation in mice. Toxicol. Lett. 2006;163:20–29

PII: S0165-0378(07)00266-5

doi: 10.1016/j.jri.2007.11.003

Journal of Reproductive Immunology
Volume 78, Issue 2 , Pages 134-139 , July 2008

Article Tools

* Image Usage & Resolution